CSIMarket
 
Avinger Inc   (AVGR)
Other Ticker:  
 
 
Price: $2.9100 $0.03 1.042%
Day's High: $3.2494 Week Perf: -12.08 %
Day's Low: $ 2.85 30 Day Perf: -1.69 %
Volume (M): 29 52 Wk High: $ 18.00
Volume (M$): $ 85 52 Wk Avg: $6.60
Open: $2.86 52 Wk Low: $2.50



 Market Capitalization (Millions $) 2
 Shares Outstanding (Millions) 1
 Employees -
 Revenues (TTM) (Millions $) 7
 Net Income (TTM) (Millions $) -20
 Cash Flow (TTM) (Millions $) -6
 Capital Exp. (TTM) (Millions $) 0

Avinger Inc
Avinger Inc is a medical device company that focuses on providing innovative solutions in the field of vascular medicine. The company develops and commercializes products for the treatment of chronic total occlusions (CTOs), which are blockages in the blood vessels that can lead to various cardiovascular diseases.

Avinger's flagship product is the Pantheris' Lumivascular atherectomy system, which is designed to remove plaque from blood vessels while avoiding damage to the vessel walls. The system incorporates real-time intravascular imaging, allowing physicians to navigate through the occlusions with precision and improve the safety and efficacy of the procedure.

In addition to Pantheris, Avinger offers a range of complementary products and devices for the treatment of peripheral artery disease (PAD) and other vascular conditions. The company aims to improve patient outcomes and reduce the need for more invasive surgical interventions through its minimally invasive and image-guided technologies.

Avinger Inc is headquartered in Redwood City, California, and its products are used by physicians and hospitals worldwide. The company is committed to advancing the field of vascular medicine through continuous research, development, and innovation.


   Company Address: 400 Chesapeake Drive Redwood City 94063 CA
   Company Phone Number: 241-7900   Stock Exchange / Ticker: NASDAQ AVGR
   


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Avinger Inc

Avinger Inc's Fiscal Q3 2023 Results Show a Mix of Promising Progress and Ominous Concerns



Avinger Inc, a medical technology company specializing in innovative imaging solutions for cardiovascular procedures, has released its financial results for the third quarter of 2023. While certain aspects of the report indicate signs of improvement, others raise concerns about the company's future. This article aims to analyze the impact of the financial results and discuss how they may shape Avinger's future trajectory.
Positive Earnings Improvement:
Despite experiencing a loss per share of $-2.92 in Q3 2023, it is worth noting that this is a substantial improvement compared to the loss per share of $-11.55 reported in the same quarter a year ago. This indicates that Avinger has made significant progress in reducing losses and moving towards profitability. Furthermore, the quarterly earnings per share (EPS) also improved from $-8.85 to $-2.92 compared to the previous quarter, showing a positive trend.

Avinger Inc

Avinger Inc. Cuts Losses Despite Revenue Decline in Q2 2023

Avinger Inc, a cutting-edge medical device company, has recently released its financial results for the second quarter of 2023. Despite a decline in revenue of -4.268% to $2.04 million, the company has managed to trim its losses, showcasing strong resilience amidst challenging market conditions.
In comparison to the previous year's quarter, Avinger Inc has shown significant improvement as the shortfall per share decreased from $-0.94 to $-0.59. Additionally, the company witnessed an impressive growth in revenue by 8.104% from $1.89 million in the previous quarter. Earnings per share also improved, moving from $-0.71 per share to a more favorable position.






 

Avinger Inc's Segments
 
 
• View Complete Report




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com